Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Deferred Taxes (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Deferred Taxes for 15 consecutive years, with $306000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Deferred Taxes rose 304.0% year-over-year to $306000.0, compared with a TTM value of $639000.0 through Dec 2025, down 52.84%, and an annual FY2025 reading of $639000.0, down 52.84% over the prior year.
  • Deferred Taxes was $306000.0 for Q4 2025 at Orthofix Medical, down from $321000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $22.3 million in Q4 2021 and bottomed at -$1.7 million in Q3 2021.
  • Average Deferred Taxes over 5 years is $1.4 million, with a median of $313500.0 recorded in 2025.
  • The sharpest move saw Deferred Taxes skyrocketed 3225.48% in 2021, then tumbled 156.09% in 2025.
  • Year by year, Deferred Taxes stood at $22.3 million in 2021, then crashed by 98.68% to $293000.0 in 2022, then plummeted by 147.78% to -$140000.0 in 2023, then fell by 7.14% to -$150000.0 in 2024, then surged by 304.0% to $306000.0 in 2025.
  • Business Quant data shows Deferred Taxes for OFIX at $306000.0 in Q4 2025, $321000.0 in Q3 2025, and -$433000.0 in Q2 2025.